Clinical trial for Heart Failure
Official title Improving Care and Mental Well-Being for Adults With Heart Failure
ClinicalTrials.gov ID: NCT07313657
What this study is testing
- What it's testing
- This study checks if a new support program called FRAME can be easily added to heart care. It aims to see if this helps doctors better notice and support patients' mental health.
- Who it's for
- Adults in Ontario, Canada, who have heart failure and are seeing a doctor for their heart or mental health.
- What's involved
- Participants will take part in the new FRAME program during their regular medical visits. They will also fill out surveys and talk with researchers about their experience.
- Time commitment
- The study involves completing surveys and interviews before and after the program, with no extra visits beyond regular care.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- Angiotensin receptor-neprilysin inhibitors (ARNI), called sacubitril-valsartan
- Angiotensin converting enzyme inhibitors (ACEi), called "prils"
- Angiotensin-receptor blockers (ARBs), called "sartans"
- Beta-blockers, called "lols"
- Mineralocorticoid receptor antagonists (MRAs)
You likely can't join if
- Inability to provide informed consent (e.g., due to cognitive impairment or language barriers without translated support)
- Participants who do not have access to the internet will not be able to use the web-tool. For Healthcare Providers
- Providers that are not involved in the care of heart failure patients
See the full eligibility criteria
- Angiotensin receptor-neprilysin inhibitors (ARNI), called sacubitril-valsartan
- Angiotensin converting enzyme inhibitors (ACEi), called "prils"
- Angiotensin-receptor blockers (ARBs), called "sartans"
- Beta-blockers, called "lols"
- Mineralocorticoid receptor antagonists (MRAs)
- Sodium-glucose co-transporter-2 (SGLT2) inhibitors, called "flozins"
- Receiving care at one of the participating pilot test sites or if they found their way to the tool website
- Caregivers who support adult(s) with heart failure.
- Inability to provide informed consent (e.g., due to cognitive impairment or language barriers without translated support)
- Participants who do not have access to the internet will not be able to use the web-tool. For Healthcare Providers
- Providers that are not involved in the care of heart failure patients
The study team makes the final eligibility decision.
Where it is enrolling
- Cornwall, Ontario, Canada
- Orléans, Ontario, Canada
- Winchester, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Cornwall, Ontario, Canada; Orléans, Ontario, Canada; Winchester, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.